Literature DB >> 24629041

Association of blood pressure with all-cause mortality and stroke in Japanese hemodialysis patients: the Japan Dialysis Outcomes and Practice Pattern Study.

Masaaki Inaba1, Angelo Karaboyas, Takashi Akiba, Tadao Akizawa, Akira Saito, Shunichi Fukuhara, Christian Combe, Bruce M Robinson.   

Abstract

The association of low blood pressure (BP) with high mortality is a characteristic for hemodialysis patients. This analysis clarifies the association of BP with mortality and stroke in Japanese hemodialysis (HD) patients and examines the association separately for patients with and without antihypertensive medication (BP meds). We analyzed 9134 patients from Japan in phases 1-4 (1999-2011) of the Dialysis Outcomes and Practice Patterns Study (DOPPS), a prospective cohort study of in-center HD patients. The association of patient systolic (SBP) and diastolic (DBP) blood pressure with all-cause and cause-specific mortality was assessed using adjusted Cox regression. A U-shaped association between BP and all-cause mortality was observed, with lowest mortality for baseline SBP 140-159 mmHg and DBP 65-74 mmHg. Both SBP and DBP were positively and monotonically associated with stroke-related death: hazard ratio (95% confidence interval) was 1.24 (1.01-1.53) per 20 mmHg higher SBP and 1.23 (1.05-1.44) per 10 mmHg higher DBP. No evidence of interaction was found between SBP and use of BP meds regarding all-cause mortality (P for interaction = 0.97); the association between SBP and stroke-related death was slightly stronger among patients not on BP meds than patients on BP meds (P for interaction = 0.09). In Japanese HD patients, both low and high BP are associated with all-cause mortality. This analysis also documents a positive and monotonic association of BP with stroke-related deaths. Although our analysis indicates that the prescription of BP meds to hypertensive patients might protect against stroke-related death, additional study is warranted.
© 2014 International Society for Hemodialysis.

Entities:  

Keywords:  Hypertension; change in blood pressure over time; outcomes research; reverse epidemiology; systolic blood pressure

Mesh:

Year:  2014        PMID: 24629041     DOI: 10.1111/hdi.12156

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  5 in total

1.  Association of optimal blood pressure with mortality in patients taking antihypertensive medications.

Authors:  Dong-Ho Yun; Hye-Sun Lee; Won-Jun Choi; Hyuk-Jae Chang; Da-Hye Son; Ji-Won Lee
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-20       Impact factor: 3.738

2.  Predialysis hypotension is not a predictor for mortality in long-term hemodialysis patients: insight from a single-center observational study.

Authors:  Wen-Hung Huang; Ching-Wei Hsu; Ching-Chih Hu; Tzung-Hai Yen; Cheng-Hao Weng
Journal:  Ther Clin Risk Manag       Date:  2016-08-24       Impact factor: 2.423

3.  Novel haemodialysis (HD) treatment employing molecular hydrogen (H2)-enriched dialysis solution improves prognosis of chronic dialysis patients: A prospective observational study.

Authors:  Masaaki Nakayama; Noritomo Itami; Hodaka Suzuki; Hiromi Hamada; Ryo Yamamoto; Kazumasa Tsunoda; Naoyuki Osaka; Hirofumi Nakano; Yukio Maruyama; Shigeru Kabayama; Ryoichi Nakazawa; Mariko Miyazaki; Sadayoshi Ito
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

4.  Circulating TNF Receptors 1 and 2 Predict Mortality in Patients with End-stage Renal Disease Undergoing Dialysis.

Authors:  Tomohito Gohda; Shuntaro Maruyama; Nozomu Kamei; Saori Yamaguchi; Terumi Shibata; Maki Murakoshi; Satoshi Horikoshi; Yasuhiko Tomino; Isao Ohsawa; Hiromichi Gotoh; Shuko Nojiri; Yusuke Suzuki
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

5.  Xanthine Oxidoreductase Inhibitor Use Associated With Reduced Risk of Sarcopenia and Severe Sarcopenia in Patients Undergoing Hemodialysis.

Authors:  Masafumi Kurajoh; Katsuhito Mori; Mizuki Miyabe; Shota Matsufuji; Akane Kizu; Yoshihiro Tsujimoto; Masanori Emoto
Journal:  Front Med (Lausanne)       Date:  2022-02-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.